Cancer health care management utilizing targeted tumor sequencing tests to detect gene mutations and aberrations in rare and common cancers to foster development of individualized treatment options for patients

'aberr':15 'cancer':1,20 'care':3 'common':19 'detect':11 'develop':23 'foster':22 'gene':12 'health':2 'individu':25 'manag':4 'mutat':13 'option':27 'patient':29 'rare':17 'sequenc':8 'target':6 'test':9 'treatment':26 'tumor':7 'util':5

[ Educational services, namely, conducting seminars, workshops and conferences in the field of molecular pathology, tumor biology and cancer care ]

'biolog':16 'cancer':18 'care':19 'conduct':4 'confer':8 'educ':1 'field':11 'molecular':13 'name':3 'patholog':14 'seminar':5 'servic':2 'tumor':15 'workshop':6

Compiling medical data for research purposes in the field of gene mutations in rare and common cancers for evaluating and assessing tumor biology, prognosis and treatment and patient drug responses

'assess':21 'biolog':23 'cancer':17 'common':16 'compil':1 'data':3 'drug':29 'evalu':19 'field':9 'gene':11 'medic':2 'mutat':12 'patient':28 'prognosi':24 'purpos':6 'rare':14 'research':5 'respons':30 'treatment':26 'tumor':22

MSK-IMPACT

Owners

Goods & Services